Diversified Healthcare Trust
DHC
$2.37
-$0.02-0.84%
| Weiss Ratings | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E+ | |||
| Rating Factors | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.54 | |||
| Price History | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.16% | |||
| 30-Day Total Return | -12.60% | |||
| 60-Day Total Return | -20.02% | |||
| 90-Day Total Return | -22.21% | |||
| Year to Date Total Return | -34.25% | |||
| 1-Year Total Return | 140.36% | |||
| 2-Year Total Return | 6.64% | |||
| 3-Year Total Return | -33.52% | |||
| 5-Year Total Return | -82.48% | |||
| 52-Week High % Change | -40.15% | |||
| 52-Week Low % Change | 149.47% | |||
| Price | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.96 | |||
| 52-Week Low Price | $0.95 | |||
| 52-Week Low Price (Date) | May 18, 2023 | |||
| 52-Week High Price (Date) | Dec 27, 2023 | |||
| Valuation | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 569.73M | |||
| Enterprise Value | 3.22B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.37 | |||
| Earnings Per Share Growth | 5.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.40 | |||
| Price/Book (Q) | 0.25 | |||
| Enterprise Value/Revenue (TTM) | 2.25 | |||
| Price | $2.37 | |||
| Enterprise Value/EBITDA (TTM) | 16.05 | |||
| Enterprise Value/EBIT | -36.34 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 239.19M | |||
| Dividend Yield | 1.69% | |||
| Div. Per Share (Most Recent) | $0.01 | |||
| Dividend Per Share (TTM) | $0.04 | |||
| Payout Ratio (TTM) | -2.93% | |||
| Dividend Per Share (Most Recent) | $0.01 | |||
| Company Info | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 796 8350 | |||
| Address | Two Newton Place Newton, MA 02458-1634 | |||
| Website | www.dhcreit.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -6.18% | |||
| Profit Margin | -22.79% | |||
| Management Effectiveness | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.01% | |||
| Return on Equity | -- | |||
| Income Statement | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 254.61M | |||
| Total Revenue (TTM) | 1.44B | |||
| Revenue Per Share | $6.00 | |||
| Gross Profit (TTM) | 228.53M | |||
| EBITDA (TTM) | 200.80M | |||
| EBIT (TTM) | -88.71M | |||
| Net Income (TTM) | -327.17M | |||
| Net Income Avl. to Common (TTM) | -327.17M | |||
| Total Revenue Growth (Q YOY) | 7.15% | |||
| Earnings Growth (Q YOY) | -63.81% | |||
| EPS Diluted (TTM) | -1.37 | |||
| EPS Diluted Growth (Q YOY) | -63.39% | |||
| Balance Sheet | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 207.12M | |||
| Cash Per Share (Q) | $0.87 | |||
| Total Current Assets (Q) | 320.97M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.25B | |||
| Current Ratio (Q) | 13.391 | |||
| Book Value Per Share (Q) | $9.35 | |||
| Total Assets (Q) | 5.35B | |||
| Total Current Liabilities (Q) | 23.97M | |||
| Total Debt (Q) | 2.86B | |||
| Total Liabilities (Q) | 3.10B | |||
| Total Common Equity (Q) | 2.25B | |||
| Cash Flow | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -204.21M | |||
| Cash from Financing (TTM) | -3.34M | |||
| Net Change in Cash (TTM) | -174.51M | |||
| Levered Free Cash Flow (TTM) | 69.45M | |||
| Cash from Operations (TTM) | 33.04M | |||
